Usefulness of CA125 and NT-proBNP for assessing congestion in chronic heart failure. Insights from CARDIOREN registry.

11 May 2024 (11:00 - 11:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Marta Cobo Marcos

Puerta de Hierro, Majadahonda (Spain)

7 More presentations in this session

Presentation thumbnail

Biomarkers associated with declining cognitive performance in patients hospitalized for acute heart failure

Doctor A. Yaghoubi (Malmoe, SE)

Abstract Slides Video

Presentation thumbnail

Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF

Doctor L. Shen (Glasgow, CN)

Abstract Slides Video

Presentation thumbnail

Proteomic biomarkers are linked to QTc interval in patients with chronic heart failure.

Mrs M. Barry-Loncq De Jong (Rotterdam, NL)

Abstract Slides Video

Presentation thumbnail

Clinical and proteomic profiles of chronic kidney disease in heart failure with preserved and reduced ejection fraction

Mr G. Voordes (Groningen, NL)

Abstract Slides Video

Presentation thumbnail

Growth differentiation factor (GDF15) profile and prognostic implications across the left ventricular ejection fraction in chronic heart failure

Doctor K. Teramoto (Osaka, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Chronic heart failure - biomarkers 1

The Event

Event poster

Heart Failure 2024

11 May 2024 11:00 CET

You may be interested in

Congress Presentation

The role of CA125 as a congestion biomarker in ischemic heart failure

Congress Presentation

How to best assess congestion with biomarkers?

Congress Presentation

Utility of CA-125 in evaluating congestion at hospital admission in patients with acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources